Opmed.ai Raises $15M
Opmed.ai, an AI optimization platform for healthcare that started with BIU’s Unbox Venture, founded by Dr. Mor Brokman Meltzer and Prof. Baruch Barzel, both of Bar-Ilan University, has successfully raised $15M in Series A funding
Opmed.ai's founders, Dr. Mor Brokman Meltzer, and Prof. Baruch Barzel of Bar-Ilan University, and Avi Paz, have developed a cutting-edge solution to address the critical challenges faced by healthcare systems worldwide, focusing not only on revenue, but also on impacting healthcare efficiency.
The AI-powered platform optimizes operating room (OR) scheduling and resource allocation for the well-being of patients and staff. By enhancing OR efficiency, the platform significantly reduces wait times for patients, ensuring they receive the care they need in a timely manner. For instance, with Opmed.ai's optimized scheduling, a patient who has been waiting for a procedure scheduled two months away, could receive a call informing her that her treatment can be accommodated within the next week's OR plan.
This expedited care not only alleviates her suffering but also minimizes the risk of potential complications arising from delayed treatment.
In addition to these crucial benefits, Opmed.ai's AI-driven optimization engine also yields substantial financial advantages for hospitals. By analyzing billions of possible scenarios and generating customized, optimized schedules, the platform drastically improves resource utilization. Hospitals can potentially gain over $1 million per OR annually while simultaneously reducing costs by $500,000. The platform's rapid implementation time of just two to four weeks, coupled with its ability to drive OR utilization up by an impressive 10%, results in significant, compounded savings and revenue.
One of the most impressive aspects of Opmed.ai's solution is its rapid implementation time. Despite the complex nature of healthcare environments, the platform can be deployed within a mere two to four weeks. Once in place, it meticulously analyses various factors such as over and underestimations, gaps, anaesthesia durations, and turnover times, generating optimized plans that streamline the scheduling process for healthcare professionals.
Renana Ashkenazi, General Partner of Grove Ventures, praised Opmed.ai, stating, "They solve a complex issue with a highly specialized vertical solution that has no alternative that comes close." The platform's clear and substantial return on investment, evident from the millions of dollars saved and generated in hospitals where it has already been deployed, has garnered enthusiasm from both investors and healthcare institutions alike.